Drug patent extensions under CETA could cost feds $270M a year: PBO

Extended patent protections under Canada’s free trade deal with the European Union could cost the federal government some $270 million a year, according to a new report by the Parliamentary Budget Officer.

The report, Patent Restoration and the Cost of Pharmaceuticals, looks at the potential cost of what are called certificates of supplementary protection – extensions of up to two years granted to drugs after the patents expire. The extensions add on to the 20-year patent protection period for drugs that have new medicinal ingredients.

source: https://ipolitics.ca/2018/04/26/drug-patent-extensions-under-ceta-could-cost-feds-270m-a-year-pbo/